NovaBridge Biosciences

Company snapshot

NovaBridge is a global biotechnology platform company committed to accelerating access to innovative medicines. We combine deep business development expertise with agile translational clinical development to identify, accelerate, and advance breakthrough assets. By bridging science, strategy, and execution, NovaBridge enables transformative therapies to progress rapidly from discovery toward patie

• 4 active pipeline program(s) linked via ClinicalTrials.gov.
• 4 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for NovaBridge Biosciences. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for NovaBridge Biosciences.

1. Jun 8, 2026 Clinical update

   mitoxantrone liposome 16 and azacitidine — Phase 2

2. Jun 5, 2026 Clinical update

   Placebo — Phase 2

3. Jun 5, 2026 Clinical update

   NBP Softgel Capsules — Phase 2

4. Jun 5, 2026 Clinical update

   Butylphthalide soft capsule — Phase 3

View all clinical trial activity →

• What is NovaBridge Biosciences?

  NovaBridge Biosciences is a pharma organization headquartered in Rockville, USA. It trades on NYSE under ticker NBP. Primary therapeutic focus areas include Vascular Dementia, Angioimmunoblastic T-cell Lymphoma, Breast Cancer. NovaPharmaNews links 4 clinical program(s), 0 drug pr

• Is NovaBridge Biosciences publicly traded?

  Yes. NovaBridge Biosciences is listed with ticker NBP on NYSE per SEC EDGAR records linked on this profile.

• What drugs does NovaBridge Biosciences develop or market?

  We link 7 drug profile(s) where NovaBridge Biosciences is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/novabridge-biosciences#company-drugs.

• What are the latest developments for NovaBridge Biosciences?

  In the last 12 months our linked public records show 4 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does NovaBridge Biosciences focus on?

  NovaBridge Biosciences focuses on Vascular Dementia, Angioimmunoblastic T-cell Lymphoma, Breast Cancer based on our analysis of their pipeline programs and drug development activities.